PRESS RELEASES

Year
December 12 | 2016
FLX Bio, Inc. Appoints Linda Kozick to its Board of Directors
December 01 | 2016
FLX Bio Announces Poster Presentations at the American Society of Hematology Conference on FLX925, a Small Molecule FLT3/CDK4/6 Inhibitor
December 01 | 2016
Cofactor Genomics Partners with FLX Bio for Immuno-Oncology Analysis Platform
April 26 | 2016
FLX Bio Announces $50 Million Series B Financing
April 05 | 2016
FLX Bio Completes Leadership Team in Immuno-Oncology Drug Discovery
February 08 | 2016
FLX Bio Hires Senior Leaders in Immuno-Oncology Drug Discovery